These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 21098404

  • 1. Brain N-acetylaspartate levels correlate with motor function in metachromatic leukodystrophy.
    i Dali C, Hanson LG, Barton NW, Fogh J, Nair N, Lund AM.
    Neurology; 2010 Nov 23; 75(21):1896-903. PubMed ID: 21098404
    [Abstract] [Full Text] [Related]

  • 2. MR-spectroscopy in metachromatic leukodystrophy: A model free approach and clinical correlation.
    Feldmann J, Martin P, Bender B, Laugwitz L, Zizmare L, Trautwein C, Krägeloh-Mann I, Klose U, Groeschel S.
    Neuroimage Clin; 2023 Nov 23; 37():103296. PubMed ID: 36563646
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Use of localized proton nuclear magnetic resonance spectroscopy in Canavan's disease.
    Aydinli N, Calişkan M, Calay M, Ozmen M.
    Turk J Pediatr; 1998 Nov 23; 40(4):549-57. PubMed ID: 10028864
    [Abstract] [Full Text] [Related]

  • 7. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec 23; 28(8):1313-22. PubMed ID: 15588758
    [Abstract] [Full Text] [Related]

  • 8. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
    Meyerhoff DJ, MacKay S, Constans JM, Norman D, Van Dyke C, Fein G, Weiner MW.
    Ann Neurol; 1994 Jul 23; 36(1):40-7. PubMed ID: 8024260
    [Abstract] [Full Text] [Related]

  • 9. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study.
    Nordahl TE, Salo R, Natsuaki Y, Galloway GP, Waters C, Moore CD, Kile S, Buonocore MH.
    Arch Gen Psychiatry; 2005 Apr 23; 62(4):444-52. PubMed ID: 15809412
    [Abstract] [Full Text] [Related]

  • 10. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U, Lais C, Rochmont Adu M, Kratzsch T, Frölich L, Maurer K, Zanella FE, Lanfermann H, Pantel J.
    Psychiatry Res; 2009 Jul 15; 173(1):1-7. PubMed ID: 19427767
    [Abstract] [Full Text] [Related]

  • 11. Localized proton magnetic resonance spectroscopy of cerebral metabolic disturbances in children with neuronal ceroid lipofuscinosis.
    Brockmann K, Pouwels PJ, Christen HJ, Frahm J, Hanefeld F.
    Neuropediatrics; 1996 Oct 15; 27(5):242-8. PubMed ID: 8971744
    [Abstract] [Full Text] [Related]

  • 12. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM, Gavrila D, Antúnez C, Tormo MJ, Salmerón D, Carles R, Jiménez Veiga J, Parrilla G, Torres del Río S, Fortuna L, Navarro C.
    Dement Geriatr Cogn Disord; 2008 Oct 15; 26(1):15-25. PubMed ID: 18566544
    [Abstract] [Full Text] [Related]

  • 13. [Estimation of postmortem interval with multivoxel-voxel proton 1H-MR spectroscopy].
    Yang TT, Li ZW, Liu L, Zheng N.
    Fa Yi Xue Za Zhi; 2007 Dec 15; 23(6):405-8. PubMed ID: 18402106
    [Abstract] [Full Text] [Related]

  • 14. 1H-magnetic resonance spectroscopy markers of cognitive and language ability in clinical subtypes of autism spectrum disorders.
    Gabis L, Wei Huang, Azizian A, DeVincent C, Tudorica A, Kesner-Baruch Y, Roche P, Pomeroy J.
    J Child Neurol; 2008 Jul 15; 23(7):766-74. PubMed ID: 18487520
    [Abstract] [Full Text] [Related]

  • 15. ALS surrogate markers. MRS.
    Kalra S, Arnold DL.
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep 15; 5 Suppl 1():111-4. PubMed ID: 15512889
    [Abstract] [Full Text] [Related]

  • 16. Brainstem proton magnetic resonance spectroscopy in idopathic REM sleep behavior disorder.
    Iranzo A, Santamaria J, Pujol J, Moreno A, Deus J, Tolosa E.
    Sleep; 2002 Dec 15; 25(8):867-70. PubMed ID: 12489892
    [Abstract] [Full Text] [Related]

  • 17. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A, Josefsen R, Kulle B, Maehlen J, Schellhorn T, Gadmar Ø, Kumar T, Haakonsen M, Langberg CW, Nakstad PH.
    Acta Radiol; 2010 Apr 15; 51(3):316-25. PubMed ID: 20092374
    [Abstract] [Full Text] [Related]

  • 18. Proton magnetic resonance spectroscopy in children with temporal lobe epilepsy.
    Cross JH, Connelly A, Jackson GD, Johnson CL, Neville BG, Gadian DG.
    Ann Neurol; 1996 Jan 15; 39(1):107-13. PubMed ID: 8572655
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Metabolite profile in the basal ganglia of children with cerebral palsy: a proton magnetic resonance spectroscopy study.
    Kulak W, Sobaniec W, Smigielska-Kuzia J, Kubas B, Walecki J.
    Dev Med Child Neurol; 2006 Apr 15; 48(4):285-9. PubMed ID: 16542516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.